TP53 and cancer: A recent study of germline variation in cancer-susceptibility genes in a healthy cohort found 15 TP53 missense variants and did not find any nonsense or frameshift variant in 681 individuals [9]; one missense variant was likely pathogenic and the others were variants of unknown clinical significance.